ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36165
-0.01%
Bitcoin
66,902.73
-0.27%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Adhera Therapeutics Inc (PK) (ATRX)

  7. Adhera Therapeutics Inc (PK) (ATRX) News

ATRX

Adhera Therapeutics (PK) (ATRX)

Adhera Therapeutics Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ATRX
DateTimeSourceHeadlineSymbolCompany
01/30/20243:00PMEdgar (US Regulatory)Form SEC STAFF ACTION - SEC Staff Action: ORDERUSOTC:ATRXAdhera Therapeutics Inc (PK)
01/18/20243:25PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
01/16/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
11/29/20233:01PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
11/20/20233:51PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ATRXAdhera Therapeutics Inc (PK)
11/15/20233:35PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ATRXAdhera Therapeutics Inc (PK)
10/12/20233:58PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
08/21/20232:32PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ATRXAdhera Therapeutics Inc (PK)
08/15/20233:05PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ATRXAdhera Therapeutics Inc (PK)
06/29/20233:54PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
05/22/20232:14PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
05/05/20233:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
05/04/20233:07PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
03/31/20232:17PMEdgar (US Regulatory)Annual Report (10-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
03/08/20233:31PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
02/23/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
01/26/20233:02PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
12/02/20224:08PMEdgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ATRXAdhera Therapeutics Inc (PK)
11/22/202212:25PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
11/14/20222:24PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
11/09/20224:19PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
09/09/20223:22PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
08/25/20223:07PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
08/18/202211:48AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
08/15/20222:48PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
07/06/20223:02PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
06/17/20223:02PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
05/16/20223:16PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
04/29/20223:58PMEdgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:ATRXAdhera Therapeutics Inc (PK)
04/21/20223:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ATRXAdhera Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:ATRX

Your Recent History

BIT
F16036
Vontobel Financial Produ...
MRTX
GEXBTC
GLOBEX
IDCM
QTUMBTC
Qtum
LSE
147Z
COIN
BONDETH
BarnBridge Governance Token
NASDAQ
ELXR
NASDAQ
UTDFX
FiveYear Global Fixed In...
BTHB
SIXKRW
SIX Network
NYSE
CNDB.WS
Concord Acquisition Corp...
LATK
CYSUSDT
Cyclos
BOV
CMIGF165
CMIGF165 Ex:16,35
ASX
HMG
Hamelin Gold
COIN
MRVBTC
TSXV
GOT
Goliath Resources
COIN
UBTCBTC
EU
FR
Valeo
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved